Literature DB >> 25026204

Sox2: masterminding the root of cancer.

Wai Leong Tam1, Huck Hui Ng2.   

Abstract

The transcription factor Sox2 is a master regulator that maintains stemness in embryonic stem cells and neural stem cells. Using elegant lineage tracing strategies and genetic reporter mouse models, two studies (one of which is by Vanner and colleagues in this issue of Cancer Cell) now demonstrate that rare Sox2-expressing cells are the founding cancer stem cell population driving tumor initiation and therapy resistance.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25026204     DOI: 10.1016/j.ccr.2014.06.024

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  27 in total

1.  Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.

Authors:  J Rodriguez-Blanco; L Pednekar; C Penas; B Li; V Martin; J Long; E Lee; W A Weiss; C Rodriguez; N Mehrdad; D M Nguyen; N G Ayad; P Rai; A J Capobianco; D J Robbins
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

2.  Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.

Authors:  Pilar Bayo; Adriana Jou; Albrecht Stenzinger; Chunxuan Shao; Madeleine Gross; Alexandra Jensen; Niels Grabe; Christel Herold Mende; Pantelis Varvaki Rados; Juergen Debus; Wilko Weichert; Peter K Plinkert; Peter Lichter; Kolja Freier; Jochen Hess
Journal:  Mol Oncol       Date:  2015-05-20       Impact factor: 6.603

3.  AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.

Authors:  Zhen Wang; Li Kang; Huifang Zhang; Yuanyong Huang; Lan Fang; Menghan Li; Peter J Brown; Cheryl H Arrowsmith; Jiwen Li; Jiemin Wong
Journal:  Oncogene       Date:  2019-03-20       Impact factor: 9.867

4.  SOX2 immunity and tissue resident memory in children and young adults with glioma.

Authors:  Juan C Vasquez; Anita Huttner; Lin Zhang; Asher Marks; Amy Chan; Joachim M Baehring; Kristopher T Kahle; Kavita M Dhodapkar
Journal:  J Neurooncol       Date:  2017-06-15       Impact factor: 4.130

5.  New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.

Authors:  Nam Hoang; Xuan Zhang; Chunxiao Zhang; Van Vo; Feng Leng; Lovely Saxena; Feng Yin; Fei Lu; Guangrong Zheng; Pradip Bhowmik; Hui Zhang
Journal:  Bioorg Med Chem       Date:  2018-02-07       Impact factor: 3.641

Review 6.  Past, present, and emerging roles of mitochondrial heat shock protein TRAP1 in the metabolism and regulation of cancer stem cells.

Authors:  Chang-Nim Im
Journal:  Cell Stress Chaperones       Date:  2016-04-12       Impact factor: 3.667

7.  SOX2 inhibits metastasis in gastric cancer.

Authors:  Yansu Chen; Yefei Huang; Liwen Zhu; Minjuan Chen; Yulin Huang; Jianbing Zhang; Song He; Aiping Li; Rui Chen; Jianwei Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-09       Impact factor: 4.553

8.  The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential.

Authors:  Juan Manuel Iglesias; Olatz Leis; Estíbaliz Pérez Ruiz; Juan Gumuzio Barrie; Francisco Garcia-Garcia; Ariane Aduriz; Izaskun Beloqui; Susana Hernandez-Garcia; Maria Paz Lopez-Mato; Joaquin Dopazo; Atanasio Pandiella; Javier A Menendez; Angel Garcia Martin
Journal:  Front Oncol       Date:  2014-11-04       Impact factor: 6.244

Review 9.  Metabostemness: a new cancer hallmark.

Authors:  Javier A Menendez; Tomás Alarcón
Journal:  Front Oncol       Date:  2014-09-29       Impact factor: 6.244

10.  Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype.

Authors:  Sune Munthe; Stine Asferg Petterson; Rikke Hedegaard Dahlrot; Frantz Rom Poulsen; Steinbjørn Hansen; Bjarne Winther Kristensen
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.